These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 9727208
1. [Soluble TNF and IL-2 receptors in patients with breast carcinoma]. Tesarová P, Kvasnicka J, Umlaufová A, Homolková J, Jirsa M, Tesar V. Cas Lek Cesk; 1998 May 25; 137(11):341-5. PubMed ID: 9727208 [Abstract] [Full Text] [Related]
2. Soluble TNF and IL-2 receptors in patients with breast cancer. Tesarová P, Kvasnicka J, Umlaufová A, Homolková H, Jirsa M, Tesar V. Med Sci Monit; 2000 May 25; 6(4):661-7. PubMed ID: 11208388 [Abstract] [Full Text] [Related]
3. [Soluble cytokinin receptors in renal vasculitis and lupus nephritis]. Tesar V, Jirsa M, Masek Z, Bartůnková J, Stejskalová A, Dostál C, Zabka J, Chábová V, Rysavá R. Cas Lek Cesk; 1998 May 04; 137(9):271-5. PubMed ID: 9650355 [Abstract] [Full Text] [Related]
4. Changes in sIL-6R and sTNF-Rs release by PMNs and the serum levels in breast cancer patients at different stages of treatment. Jablonska E. Cytokine; 1998 Jul 04; 10(7):540-3. PubMed ID: 9702418 [Abstract] [Full Text] [Related]
5. [Changes of proinflammatory cytokines and their receptors in serum from patients with pulmonary tuberculosis]. Tang S, Xiao H, Fan Y, Wu F, Zhang Z, Li H, Yang Y. Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun 04; 25(6):325-9. PubMed ID: 12126553 [Abstract] [Full Text] [Related]
6. Soluble cytokine receptors in renal vasculitis and lupus nephritis. Tesar V, Jirsa M, Zima T, Kalousová M, Bartunková J, Stejskalová A, Dostál C, Zabka J. Med Sci Monit; 2002 Jan 04; 8(1):BR24-9. PubMed ID: 11782670 [Abstract] [Full Text] [Related]
7. [Tumor necrosis factor alpha and its soluble receptors in serum of patients with coronary artery disease]. Mizia-Stec K, Mandecki T, Zahorska-Markiewicz B, Janowska J, Szulc A, Jastrzebska-Maj E, Szymański L. Pol Merkur Lekarski; 2001 Jul 04; 11(61):19-25. PubMed ID: 11579824 [Abstract] [Full Text] [Related]
8. Tumor necrosis factor-alpha and soluble tumor necrosis factor receptors in the culture supernatants of polymorphonuclear cells and peripheral blood mononuclear cells from cancer patients. Jablońska E, Kiluk M, Piotrowski L, Grabowska Z, Markiewicz W, Jablonski J. Eur Cytokine Netw; 1998 Jun 04; 9(2):155-9. PubMed ID: 9681391 [Abstract] [Full Text] [Related]
9. Systemic release of soluble TNF receptors after high-dose TNF in isolated limb perfusion. Gérain J, Liénard D, Pampallona S, Baumgartner M, Rüegg C, Buurman WA, Eggermont A, Lejeune F. Cytokine; 1997 Dec 04; 9(12):1034-42. PubMed ID: 9417816 [Abstract] [Full Text] [Related]
10. Diurnal and sleep-wake dependent variations of soluble TNF- and IL-2 receptors in healthy volunteers. Haack M, Pollmächer T, Mullington JM. Brain Behav Immun; 2004 Jul 04; 18(4):361-7. PubMed ID: 15157953 [Abstract] [Full Text] [Related]
11. [Significance of tumor necrosis factor-alpha gene polymorphism in patients with acute severe pancreatitis]. Zhang D, Li J, Jiang Z, Yu B, Tang X. Zhonghua Yi Xue Za Zhi; 2002 Nov 25; 82(22):1529-31. PubMed ID: 12609060 [Abstract] [Full Text] [Related]
12. [Soluble adhesive molecules and cytokines in patients with myasthenia gravis treated with plasmapheresis]. Tesar V, Jelínková E, Jirsa M, Bakosová N, Pit'ha V, Chábová V. Cas Lek Cesk; 1998 Nov 02; 137(21):654-9. PubMed ID: 9929930 [Abstract] [Full Text] [Related]
13. Expression of tumor necrosis factor-alpha and its soluble receptors in betel-quid-chewing patients at different stages of treatment for oral squamous cell carcinoma. Su TR, Chang KL, Lee CH, Chen CH, Yang YH, Shieh TY. Oral Oncol; 2004 Sep 02; 40(8):804-10. PubMed ID: 15288835 [Abstract] [Full Text] [Related]
14. Upregulation of cytokine receptors sTNF-R55, sTNF-R75, and sIL-2R in psoriatic arthritis synovial fluid. Partsch G, Wagner E, Leeb BF, Dunky A, Steiner G, Smolen JS. J Rheumatol; 1998 Jan 02; 25(1):105-10. PubMed ID: 9458212 [Abstract] [Full Text] [Related]
15. Clinical significance of measuring levels of tumor necrosis factor-alpha and soluble interleukin-2 receptor in nasopharyngeal carcinoma. Hsiao SH, Lee MS, Lin HY, Su YC, Ho HC, Hwang JH, Lee CC, Hung SK. Acta Otolaryngol; 2009 Dec 02; 129(12):1519-23. PubMed ID: 19922107 [Abstract] [Full Text] [Related]
16. Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients with gastric cancer. Szaflarska A, Szczepanik A, Siedlar M, Czupryna A, Sierzega M, Popiela T, Zembala M. Anticancer Res; 2009 Dec 02; 29(12):5005-12. PubMed ID: 20044609 [Abstract] [Full Text] [Related]
17. Reduction of plasma levels of soluble tumor necrosis factor and interleukin-2 receptors by means of a novel immunoadsorption column. Lentz M, Kumar K. Ther Apher Dial; 2008 Dec 02; 12(6):491-9. PubMed ID: 19140848 [Abstract] [Full Text] [Related]
18. [Interleukin-6, tumor necrosis factor alpha and their soluble receptors in Bence-Jones nephropathy. Possible role in pathogenesis andthe importance in the determination of prognosis in renal insufficiency]. Spicka I, Masek Z, Jirsa M, Zounar R, Procházka B, Merta M, Cieslar P, Tesar V, Klener P. Cas Lek Cesk; 1998 May 04; 137(9):267-70. PubMed ID: 9650354 [Abstract] [Full Text] [Related]
19. Release of soluble tumor necrosis factor receptors from polymorphonuclear cells of breast cancer patients. Jabłońska E, Pietruska Z. Arch Immunol Ther Exp (Warsz); 1997 May 04; 45(5-6):449-53. PubMed ID: 9437501 [Abstract] [Full Text] [Related]
20. Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. Shearer WT, Reuben JM, Mullington JM, Price NJ, Lee BN, Smith EO, Szuba MP, Van Dongen HP, Dinges DF. J Allergy Clin Immunol; 2001 Jan 04; 107(1):165-70. PubMed ID: 11150007 [Abstract] [Full Text] [Related] Page: [Next] [New Search]